Fatty Acid Oxidation Disorders (FAODs) Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Fast Is The Fatty Acid Oxidation Disorders (FAODs) Market Expected to Grow Between 2025 And 2029?
In recent times, there has been a significant increase in the fatty acid oxidation disorders (faods) market size. The anticipated growth is expected to raise the market size from $9.55 billion in 2024 to $10.23 billion in 2025, displaying a compound annual growth rate (CAGR) of 7.2%. Factors leading to this growth in the historical period can be identified as heightened awareness, a surge in the occurrence of rare and genetic disorders, an increase in product clearance, amplified government initiatives, and growing demand for orphan drugs.
In the coming years, the market size for fatty acid oxidation disorders (faods) is anticipated to experience robust expansion. Expected to reach a total of $13.68 billion in 2029, it will see a compound annual growth rate (CAGR) of 7.5%. Factors such as the growing requirement for sustainable bio-products, the rise in customized medicine use, initial diagnosis of FAODS, increased research and development financing, and an enhanced focus on advancing long-term results contribute to this growth during the forecast period. Prominent trends during this time frame comprise of the incorporation of telehealth services, employment of artificial intelligence in diagnostics and drug discovery, progression in genetic testing, technological advancements, and a shift towards patient-centric care models.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21964&type=smp
Which Primay Drivers Are Accelerating Growth in the Fatty Acid Oxidation Disorders (FAODs) Market?
The fatty acid oxidation disorders (FAODs) market is expected to flourish due to a surge in the demand for gene therapy. Gene therapy, a medical procedure that modifies or replaces defective genes to treat or stave-off diseases, has witnessed an increase in demand due to its capabilities of treating genetic disorders, cancer, and rare diseases by addressing the underlying genetic factors. This has led to substantial investments and advancements in the field of biotechnology. By delivering functional genes, gene therapy aims to rectify metabolic deficiencies caused by fatty acid oxidation disorders. It boosts enzymatic activity, increases energy production, and avoids disease complications. For instance, in April 2024, the American Society of Gene & Cell Therapy reported a 10% increase in Phase III clinical trials of gene therapies in the fourth quarter. This is the first growth of its kind since the third quarter of 2022. Hence, the escalating demand for gene therapy is fueling the growth of the fatty acid oxidation disorders (FAODs) market.
Which Primary Segments of the Fatty Acid Oxidation Disorders (FAODs) Market Are Driving Growth and Industry Transformations?
The fatty acid oxidation disorders (faods)market covered in this report is segmented –
1) By Type: Long Chain; Short Chain
2) By Drug Type: Levocarnitine; Dextrose; Riboflavin; Other Drug Types
3) By Route of Administration: Oral; Intravenous
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Drug Stores; Online Stores
5) By End User: Hospitals; Clinics; Pharmaceutical Companies
Subsegments:
1) By Long Chain: Very Long-Chain Acyl-CoA Dehydrogenase Deficiency (VLCAD); Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency (LCHAD); Trifunctional Protein Deficiency (TFP); Carnitine Palmitoyltransferase II Deficiency (CPT II)
2) By Short Chain: Medium-Chain Acyl-CoA Dehydrogenase Deficiency (MCAD); Short-Chain Acyl-CoA Dehydrogenase Deficiency (SCAD); Carnitine Uptake Defect (CUD)
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=21964&type=smp
Which Regions Are Key Players in the Growth of the #Which Primay Drivers Are Accelerating Growth in the Fatty Acid Oxidation Disorders (FAODs) Market?# Market?
Asia-Pacific was the largest region in the fatty acid oxidation disorders (FAODs) market in 2024. The regions covered in the fatty acid oxidation disorders (FAODs) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Which Technological Trends Are Reshaping the Fatty Acid Oxidation Disorders (FAODs) Industry Dynamics?
Leading firms in the fatty acid oxidation disorders (FAODs) sector are striving to create novel solutions such as peroxisome proliferator-activated receptor delta (PPARd) agonists. These aim to boost metabolic regulation and elevate the success rate of FAOD treatments. PPARd agonists activate the PPARd receptor, a key component in controlling lipid metabolism, inflammation, and energy equilibrium, and could potentially offer therapeutic benefits for metabolic and cardiovascular illnesses. To illustrate, Reneo Pharmaceuticals Inc., an established clinical-stage pharmaceutical enterprise based in the US, was granted Fast Track status by the U.S. Food and Drug Administration (FDA) in January 2023 for its trial drug, Mavodelpar (REN001). This drug particularly targets a genotype associated with long-chain fatty acid oxidation disorder (LC-FAOD), known as long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency. Through the activation of PPARd, Mavodelpar seeks to reinforce mitochondrial function, optimize energy metabolism, and alleviate LC-FAOD related symptoms.
View the full report here:
What Parameters Are Used to Define the Fatty Acid Oxidation Disorders (FAODs) Market?
Fatty acid oxidation disorders (FAODs) are a group of rare genetic metabolic disorders that impair the body’s ability to convert fats into energy due to a deficiency or absence of specific enzymes required for fatty acid breakdown. Fatty acid oxidation disorders lead to an accumulation of fatty acids in the body, which can cause severe energy deficiency, hypoglycemia, muscle weakness, and potential organ damage, particularly during periods of fasting or illness.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21964
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
